A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness

This study aimed to develop a microsimulation model to estimate the health effects, costs, and cost-effectiveness of public health and clinical interventions for preventing/managing type 2 diabetes. We combined newly developed equations for complications, mortality, risk factor progression, patient...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health Jg. 26; H. 9; S. 1372 - 1380
Hauptverfasser:	Hoerger, Thomas J., Hilscher, Rainer, Neuwahl, Simon, Kaufmann, Matthew B., Shao, Hui, Laxy, Michael, Cheng, Yiling J., Benoit, Stephen, Chen, Haiying, Anderson, Andrea, Craven, Tim, Yang, Wenya, Cintina, Inna, Staimez, Lisa, Zhang, Ping
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 01.09.2023
Schlagworte:	Adult Cost-Benefit Analysis diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - therapy Glycated Hemoglobin Humans Internal Medicine microsimulation Middle Aged Outcome Assessment, Health Care probabilistic sensitivity analysis Public Health Quality-Adjusted Life Years risk equations United States - epidemiology United States probabilistic sensitivity analysis risk equations diabetes microsimulation
ISSN:	1098-3015, 1524-4733, 1524-4733
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!